<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The incidence of distal oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is rising, with <z:hpo ids='HP_0011010'>chronic</z:hpo> reflux and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> being considered risk factors </plain></SENT>
<SENT sid="1" pm="."><plain>Reliable detection of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> during upper endoscopy is therefore mandatory but requires both endoscopy and histology for confirmation </plain></SENT>
<SENT sid="2" pm="."><plain>Appropriate management of patients with endoscopic suspicion but negative on histology, or vice versa, or of patients with no endoscopic suspicion but with a biopsy diagnosis of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> at the gastro-oesophageal junction, has not yet been studied prospectively </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: In a prospective multicentre study, 929 patients (51% male, mean age 50 years) referred for upper gastrointestinal endoscopy were included; 59% had reflux symptoms </plain></SENT>
<SENT sid="4" pm="."><plain>The endoscopic aspect of the Z line and any suspicion of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were noted, and biopsies were taken in <z:hpo ids='HP_0000001'>all</z:hpo> patients from the Z line (n = 4), gastric cardia (n = 2), and body and antrum (n = 2 each) </plain></SENT>
<SENT sid="5" pm="."><plain>Biopsies positive for specialised <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (SIM) were reviewed by a reference pathologist for a final <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with endoscopic and/or histological suspicion of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were invited for a follow up endoscopy; the remaining cases (no endoscopic or histological suspicion of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>) were followed clinically </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Of 235 patients positive for <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> on endoscopy and/or histology, 63% agreed to undergo repeat endoscopy (mean follow up period 30.5 months) </plain></SENT>
<SENT sid="8" pm="."><plain>46% of patients with an endoscopic <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> diagnosis but no histological confirmation (group A) showed the same distribution, a further 42% did not have <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, and 11% had confirmed <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> on both endoscopy and biopsy on follow up </plain></SENT>
<SENT sid="9" pm="."><plain>In the group with a histological <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> diagnosis but negative on initial endoscopy (group B), follow up showed the same in 26% whereas 46% had no <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, and confirmed <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (endoscopy plus histology) was diagnosed in 17% </plain></SENT>
<SENT sid="10" pm="."><plain>Of the study population, 16 patients had <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> on initial endoscopy confirmed by histology which remained constant in 70% at follow up (group C) </plain></SENT>
<SENT sid="11" pm="."><plain>Of the remaining patients without an initial <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> diagnosis on either endoscopy or histology (group D) and only clinical follow up (mean follow up period 38 months), one confirmed <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> case was found among 100 patients re-endoscoped outside of the study protocol </plain></SENT>
<SENT sid="12" pm="."><plain>However, no single case of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> of the distal oesophagus was detected in any patient during the study period </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Even in a specialised gastroenterology setting, reproducibility of presumptive endoscopic or histological diagnoses of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> at follow up were poor </plain></SENT>
<SENT sid="14" pm="."><plain>Only 10-20% of cases with either endoscopic or histological suspicion of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> had established <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> after 2.5 years of follow up </plain></SENT>
<SENT sid="15" pm="."><plain>The risk of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in this population was very low and hence meticulous follow up may not be required </plain></SENT>
</text></document>